methylphenidate

(redirected from Ritalin SR)
Also found in: Dictionary, Thesaurus.

methylphenidate

 [meth″il-fenĭ-dāt]
a mild central nervous system stimulant; the hydrochloride salt is administered orally in the treatment of attention-deficit/hyperactivity disorder and narcolepsy.

methylphenidate

/meth·yl·phen·i·date/ (meth″il-fen´ĭ-dāt) a central stimulant, used in the form of the hydrochloride salt in the treatment of attention-deficit in children and narcolepsy.

methylphenidate

(mĕth′əl-fĕn′ĭ-dāt′, -fē′nĭ-)
n.
A drug, C14H19NO2, chemically related to amphetamine, that acts as a mild stimulant of the central nervous system and is used in its hydrochloride form to treat attention deficit hyperactivity disorder and narcolepsy.

methylphenidate

An amphetamine-derived CNS stimulant.
 
Adverse effects
Decreased appetite—10–15% of children have major weight loss; insomnia—most suffer sleep delay; abdominal pain; headaches; dry mouth; dizziness; depression, tachycardia; a proposed link to decreased growth is uncertain.
 
Indications for
Hyperactivity, ADD, childhood narcolepsy.

methylphenidate

Ritalin® Neuropharmacology An amphetamine derived CNS stimulant used to control ADD and hyperactivity in children Adverse effects ↓ Appetite, 10-15% of children have major weight loss; insomnia–most suffer sleep delay, abdominal pain, headaches, dry mouth, dizziness, depression, tachycardia; link with ↓ growth is uncertain Used for Hyperactivity; narcolepsy; ADD. See Amphetamine.

methylphenidate

A nervous system stimulant drug that, paradoxically, has been found effective in the management of ATTENTION-DEFICIT HYPERACTIVITY DISORDER in children. A brand name is Ritalin. The current consensus of opinion on the use of this drug for this purpose is that it is grossly over-prescribed, especially in the USA.

methylphenidate

a central nervous system stimulant used in the treatment of hyperkinesis and narcolepsy in dogs.
References in periodicals archive ?
Ritalin LA joins the Novartis ADHD product portfolio, which includes Ritalin, Ritalin SR, and Focalin(TM) (dexmethylphenidate HCl).
The Novartis ADHD product portfolio includes Ritalin (R) (methylphenidate), Ritalin SR, and Focalin (TM) (dexmethylphenidate HCl), a refined formulation of Ritalin.
Ritalin LA joins the Novartis ADD/ADHD portfolio, which also includes Ritalin, Ritalin SR and Focalin(TM), and offers multiple therapy options to effectively treat each ADD/ADHD patient.
Upon approval, Ritalin LA will join the Novartis ADHD product portfolio, which will include Ritalin, Ritalin SR (methylphenidate HCl sustained-release tablets), and dexmethylphenidate HCl, a refined formulation of Ritalin.